(Q63816562)
Statements
Double-blind, Randomized, Vehicle-controlled, Multicenter, Multinational, Parallel-group Study of the Efficacy and Safety of ZK245186 Ointment in Concentrations of 0.01, 0.03, and 0.1% Over 4 Weeks in Patients With Atopic Dermatitis (AD) (English)
0 references
November 2010
0 references
July 2011
0 references
263
0 references
18 year
0 references
55 year
0 references